| The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. A Waage, P Brandtzaeg, A Halstensen, P Kierulf, T Espevik The Journal of experimental medicine 169 (1), 333-338, 1989 | 1539 | 1989 |
| Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease A Waage, A Halstensen, T Espevik The Lancet 329 (8529), 355-357, 1987 | 1444 | 1987 |
| Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma A Palumbo, SV Rajkumar, MA Dimopoulos, PG Richardson, J San Miguel, ... Leukemia 22 (2), 414-423, 2008 | 1022 | 2008 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 1007 | 2012 |
| Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. A Waage, A Halstensen, R Shalaby, P Brandtzaeg, P Kierulf, T Espevik The Journal of experimental medicine 170 (6), 1859-1867, 1989 | 628 | 1989 |
| Hyperhomocysteinemia and venous thrombosis: a meta-analysis M Den Heijer, FR Rosendaal, HJ Blom, WBJ Gerrits, GMJ Bos Thrombosis and haemostasis 80 (12), 874-877, 1998 | 559 | 1998 |
| Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4 B Dybdahl, A Wahba, E Lien, TH Flo, A Waage, N Qureshi, OFM Sellevold, ... Circulation 105 (6), 685-690, 2002 | 498 | 2002 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 435 | 2016 |
| Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo MR Shalaby, A Waage, L Aarden, T Espevik Clinical immunology and immunopathology 53 (3), 488-498, 1989 | 403 | 1989 |
| Thalidomide for treatment of multiple myeloma: 10 years later A Palumbo, T Facon, P Sonneveld, J Blade, M Offidani, F Gay, P Moreau, ... Blood, The Journal of the American Society of Hematology 111 (8), 3968-3977, 2008 | 401 | 2008 |
| Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy SL Opsjøn, NC Wathen, S Tingulstad, G Wiedswang, A Sundan, A Waage, ... American Journal of Obstetrics and Gynecology 169 (2), 397-404, 1993 | 394 | 1993 |
| Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials PM Fayers, A Palumbo, C Hulin, A Waage, P Wijermans, M Beksaç, ... Blood, The Journal of the American Society of Hematology 118 (5), 1239-1247, 2011 | 348 | 2011 |
| Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. A Waage, T Espevik The Journal of experimental medicine 167 (6), 1987-1992, 1988 | 342 | 1988 |
| Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data A Palumbo, S Bringhen, SK Kumar, G Lupparelli, S Usmani, A Waage, ... The lancet oncology 15 (3), 333-342, 2014 | 334 | 2014 |
| Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells T Standal, C Seidel, Ø Hjertner, T Plesner, RD Sanderson, A Waage, ... Blood, The Journal of the American Society of Hematology 100 (8), 3002-3007, 2002 | 333 | 2002 |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and … M Cavo, F Gay, M Beksac, L Pantani, MT Petrucci, MA Dimopoulos, ... The Lancet Haematology 7 (6), e456-e468, 2020 | 326 | 2020 |
| Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts A Waage, G Slupphaug, R Shalaby European Journal of Immunology 20 (11), 2439-2443, 1990 | 318 | 1990 |
| Serum syndecan-1: a new independent prognostic marker in multiple myeloma C Seidel, A Sundan, M Hjorth, I Turesson, IMS Dahl, N Abildgaard, ... Blood, The Journal of the American Society of Hematology 95 (2), 388-392, 2000 | 310 | 2000 |
| Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma A Waage, P Gimsing, P Fayers, N Abildgaard, L Ahlberg, B Björkstrand, ... Blood, The Journal of the American Society of Hematology 116 (9), 1405-1412, 2010 | 286 | 2010 |
| The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network E Terpos, O Sezer, PI Croucher, R García-Sanz, M Boccadoro, ... Annals of Oncology 20 (8), 1303-1317, 2009 | 282 | 2009 |
